CYAD

Celyad Oncology SA American Depositary Shares

Delisted

CYAD was delisted on the 18th of May, 2023.

9 hedge funds and large institutions have $9.23M invested in Celyad Oncology SA American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
9
Holders Change
+1
Holders Change %
+12.5%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
4
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Victory Capital Management
1
Victory Capital Management
Texas
$8.52M -$13M -1,200,976 -60%
Morgan Stanley
2
Morgan Stanley
New York
$343K -$83K -7,748 -19%
Millennium Management
3
Millennium Management
New York
$175K -$9.36K -864 -5%
Renaissance Technologies
4
Renaissance Technologies
New York
$110K +$110K +10,300 New
Wells Fargo
5
Wells Fargo
California
$63K -$10.6K -1,000 -14%
UBS Group
6
UBS Group
Switzerland
$17K +$5.51K +527 +48%
Bank of Montreal
7
Bank of Montreal
Ontario, Canada
$1K
Deutsche Bank
8
Deutsche Bank
Germany
-$4K -500 Closed